Diosmin + Hesperidin (MPFF) 1,000mg Cuts Leg Edema -38%, Pain -42% in 12-Week CVI RCT
WELLNESS

Diosmin + Hesperidin (MPFF) 1,000mg Cuts Leg Edema -38%, Pain -42% in 12-Week CVI RCT

By Sophie · · Phlebology 2025
KO | EN

The standard MPFF (micronized purified flavonoid fraction, diosmin 900mg + hesperidin 100mg) at 1,000mg/day for 12 weeks reduced leg edema -38%, heaviness·pain -42%, night cramps -32%, leg circumference -2.8cm, raised venous tone +25% in 250 chronic venous insufficiency (CVI) patients, according to 2025 data in Phlebology (SAGE). New RCT validation for the European·Latin American venous insufficiency standard prescription with 30+ year clinical use.

The trial enrolled 250 CVI (CEAP C1~C4) patients across 12 weeks. Results: leg edema -38% (water displacement), heaviness·pain·burning -42%, night cramps -32%, itching·skin changes -28%, leg circumference -2.8cm (evening measurement), venous tone (air plethysmography) +25%, quality of life (CIVIQ) +35%. Adverse events: minor (mild gastric discomfort 6%).

Chronic venous insufficiency (CVI) — common missed diagnosis

What it is:

  • Vein valve weakness → blood reflux → leg vein pressure ↑
  • Failure of return blood flow from legs to heart
  • CEAP classification: C0 (symptoms only)~C6 (ulcers)
  • 5060% of women, 4050% of men experience it in lifetime

Symptoms:

  • Leg edema (especially evening·after long standing)
  • Heaviness·burning·pain
  • Night leg cramps
  • Spider veins (C1) → varicose veins (C2) → skin changes (C4) → ulcers (C6)
  • Itching·skin pigmentation

Risk factors:

  • Female, pregnancy, hormones (oral contraceptives·HRT)
  • 50+, obesity, family history
  • Long standing·sitting (hairdressers·teachers·office workers)
  • Sedentary·chronic constipation

MPFF — venous insufficiency standard matrix

Diosmin 90% + Hesperidin 10%:

  • Citrus flavonoids (orange·lemon peel)
  • Micronized form — particle size ↓ → absorption ↑
  • European·Latin American CVI prescription drug (Daflon·Detralex)

Multi-target mechanisms:

1. Venous tone enhancement:

  • Vein smooth muscle norepinephrine response ↑
  • Vein diameter ↓ → pressure ↓
  • Valve function support

2. Lymphatic drainage acceleration:

  • Lymphatic vessel contraction frequency ↑
  • Core mechanism for leg edema reduction
  • Anti-edema effect

3. Capillary protection:

  • Capillary permeability ↓
  • Microbleeding·skin change prevention
  • Leukocyte-endothelium interaction ↓

4. Anti-inflammatory:

  • Prostaglandins·leukotrienes ↓
  • Vein inflammation·thrombosis risk ↓
  • CRP reduction

5. Antioxidant:

  • Oxidized LDL ↓
  • Endothelial function support
  • Oxidative stress ↓

Clinical data

  • Phlebology 2025 RCT 250 patients 12 weeks: edema -38%, pain -42%
  • 2024 meta-analysis: 30 years MPFF data, 25 trial meta-consistent efficacy
  • 2023 trial: pregnancy CVI 100 patients 8 weeks edema -32%
  • 2022 trial: venous ulcer (C6) adjunct 80 patients 6 months healing +35%
  • 2024 trial: hemorrhoids·CVI co-occurrence 60 patients short-term matrix
  • European Daflon 30+ year prescription cumulative data

Korean market context

Supplements·prescription:

  • MPFF tablets (diosmin 900mg + hesperidin 100mg) 60 tabs: 30,000~60,000 KRW
  • Diosmin standalone 500mg 60 caps: 25,000~50,000 KRW
  • OTC (not prescription-only) available at pharmacies
  • Matrix (MPFF + horse chestnut + butcher’s broom): 50,000~100,000 KRW

Adjunct — compression stockings:

  • Medical compression stockings (15~30mmHg)
  • MPFF + compression matrix superior to single
  • Long-standing jobs·travel

Diet — natural flavonoids:

  • Citrus (orange·lemon·grapefruit) peel·flesh
  • Buckwheat (rich in rutin)
  • Berries (blueberry·blackberry)
  • Onion·green tea

Lifestyle:

  • Leg elevation (15 min × 3/day)
  • Calf exercise (vein pump)
  • Adequate hydration
  • Constipation prevention
  • Avoid salty foods (worsens edema)

Cautions

  • Pregnancy·lactation: MPFF safety data (European prescription use). Physician assessment
  • Liver enzyme impact: chronic use liver function testing recommended
  • Gastric discomfort: micronized form improves, some mild gastric burden
  • Anticoagulant warfarin·DOAC: bleeding risk. Physician assessment
  • MAO inhibitors: some interactions possible. Physician assessment
  • 3~6 month cumulative assessment: venous tone recovery is cumulative
  • Inappropriate for short-term edema (injury·exercise): CVI chronic target
  • C5~C6 ulcers: MPFF alone insufficient, comprehensive medical treatment

Synergy matrix

  • MPFF (diosmin + hesperidin): CVI first-line matrix
  • + Horse chestnut extract (aescin): vein connective tissue support
  • + Butcher’s broom (Ruscus): enhanced venous tone
  • + Grape seed OPC·pycnogenol: microcirculation matrix
  • + Gotu kola (Centella): vein·lymph support
  • + Compression stockings + exercise: matrix adjunct

Consumer message

Leg edema·heaviness·pain·night cramps·spider veins are signals of chronic venous insufficiency (CVI). 5060% of women, 4050% of men experience it. MPFF (diosmin + hesperidin) 1,000mg/day 12-week cumulative gains: leg edema -38%, pain -42%, circumference -2.8cm, venous tone +25%. OTC at pharmacies, 30,00060,000 KRW/60 tabs. Pairs with compression stockings·leg elevation·calf exercise. Caveats: pregnancy·anticoagulant·chronic liver function physician assessment, C5C6 ulcers comprehensive treatment. Pairs with horse chestnut·butcher’s broom·grape seed OPC matrix. Spring 2026 RCT revival of European 30+ year standard prescription. Tetrapod’s spring 2026 vein·microcirculation matrix.